Let's be real - there is no strategic mastery at play here. Treagus (or any biotech/medtech/whatever tech) CEO is doing what we're all doing, taking a punt on a promising speck of the market and praying for it all to align.
Ann: Neuren approaching key milestones in Q4 2019, page-30
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.66 |
Change
0.090(0.58%) |
Mkt cap ! $2.001B | |||
| Open | High | Low | Value | Volume |
| $15.40 | $16.06 | $15.36 | $5.134M | 327.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 929 | $15.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.66 | 88 | 4 |
View Market Depth
| Last trade - 15.02pm 19/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |